Cyclic GMP

phosphodiesterase 2A ; Rattus norvegicus







59 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33970224 CNP regulates cardiac contractility and increases cGMP near both SERCA and TnI: difference from BNP visualized by targeted cGMP biosensors. 2022 May 6 2
2 35506379 Abnormal Cyclic Nucleotide Signaling at the Outer Mitochondrial Membrane In Sympathetic Neurons During the Early Stages of Hypertension. 2022 Jul 1
3 30835157 Reduced phosphodiesterase-2 activity in the amygdala results in anxiolytic-like effects on behavior in mice. 2019 May 1
4 31100470 PDE2 regulates membrane potential, respiration and permeability transition of rodent subsarcolemmal cardiac mitochondria. 2019 Jul 4
5 31121256 Effect of phosphodiesterase (1B, 2A, 9A and 10A) inhibitors on central nervous system cyclic nucleotide levels in rats and mice. 2019 Oct 1
6 31253692 Target Engagement of a Phosphodiesterase 2A Inhibitor Affecting Long-Term Memory in the Rat. 2019 Sep 7
7 31521738 TAK-915, a phosphodiesterase 2A inhibitor, ameliorates the cognitive impairment associated with aging in rodent models. 2019 Dec 30 2
8 29440309 Phosphodiesterase 2A Inhibitor TAK-915 Ameliorates Cognitive Impairments and Social Withdrawal in N-Methyl-d-Aspartate Receptor Antagonist-Induced Rat Models of Schizophrenia. 2018 Apr 2
9 29720569 Phosphodiesterase 2A as a therapeutic target to restore cardiac neurotransmission during sympathetic hyperactivity. 2018 May 3 4
10 30051530 17β-Estradiol reduces mitochondrial cAMP content and cytochrome oxidase activity in a phosphodiesterase 2-dependent manner. 2018 Oct 1
11 30651902 Low-Concentration Oxygen/Ozone Treatment Attenuated Radiculitis and Mechanical Allodynia via PDE2A-cAMP/cGMP-NF-κB/p65 Signaling in Chronic Radiculitis Rats. 2018 1
12 28283839 Selective phosphodiesterase-2A inhibitor alleviates radicular inflammation and mechanical allodynia in non-compressive lumbar disc herniation rats. 2017 Jul 1
13 25916722 Efficacy of B-Type Natriuretic Peptide Is Coupled to Phosphodiesterase 2A in Cardiac Sympathetic Neurons. 2015 Jul 1
14 25939307 Angiotensin-converting enzyme inhibition prevents myocardial infarction-induced increase in renal cortical cGMP and cAMP phosphodiesterase activities. 2015 Aug 1
15 26178667 Inhibition of PDE2A, but not PDE9A, modulates presynaptic short-term plasticity measured by paired-pulse facilitation in the CA1 region of the hippocampus. 2015 Oct 2
16 24184653 Select 3',5'-cyclic nucleotide phosphodiesterases exhibit altered expression in the aged rodent brain. 2014 Feb 2
17 24424715 Differential regulation of C-type natriuretic peptide-induced cGMP and functional responses by PDE2 and PDE3 in failing myocardium. 2014 May 11
18 24531807 PDE2-mediated cAMP hydrolysis accelerates cardiac fibroblast to myofibroblast conversion and is antagonized by exogenous activation of cGMP signaling pathways. 2014 Apr 15 5
19 24837549 Phosphodiesterase 2 negatively regulates adenosine-induced transcription of the tyrosine hydroxylase gene in PC12 rat pheochromocytoma cells. 2014 Jul 5 4
20 24899690 Inhibition of phosphodiesterase 2 augments cGMP and cAMP signaling to ameliorate pulmonary hypertension. 2014 Aug 5 2
21 23597790 Discovery of potent selective bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model. Part II: optimization studies and demonstration of in vivo efficacy. 2013 Jun 1 2
22 23810893 Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes. 2013 Oct 22 5
23 21330599 cGMP signals modulate cAMP levels in a compartment-specific manner to regulate catecholamine-dependent signaling in cardiac myocytes. 2011 Apr 15 7
24 21653225 cGMP phosphodiesterase inhibition improves the vascular and metabolic actions of insulin in skeletal muscle. 2011 Aug 2
25 20139324 Intrinsic sex-specific differences in microvascular endothelial cell phosphodiesterases. 2010 Apr 1
26 20196107 Expression and function of phosphodiesterases in nitrofen-induced congenital diaphragmatic hernia in rats. 2010 Apr 2
27 20213343 Cyclic GMP and nitric oxide synthase in aging and Alzheimer's disease. 2010 Jun 2
28 21151982 Concerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin II. 2010 Dec 3 5
29 19632989 Dual acylation of PDE2A splice variant 3: targeting to synaptic membranes. 2009 Sep 18 2
30 18499090 The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging. 2008 Jun 24 1
31 18501878 NO-mediated cGMP synthesis in cultured cholinergic neurons from the basal forebrain of the fetal rat. 2008 Jun 27 2
32 18655195 In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats. 2008 Nov 15 7
33 18684888 cGMP decreases surface NKCC2 levels in the thick ascending limb: role of phosphodiesterase 2 (PDE2). 2008 Oct 5
34 18957291 Phosphodiesterase 2 and 5 inhibition attenuates the object memory deficit induced by acute tryptophan depletion. 2008 Dec 14 3
35 17141339 Expression and activity of cGMP-dependent phosphodiesterases is up-regulated by lipopolysaccharide (LPS) in rat peritoneal macrophages. 2007 Feb 4
36 17302738 Changes in purine specificity in tandem GAF chimeras from cyanobacterial cyaB1 adenylate cyclase and rat phosphodiesterase 2. 2007 Mar 3
37 17407767 Changes in NMDA receptor-induced cyclic nucleotide synthesis regulate the age-dependent increase in PDE4A expression in primary cortical cultures. 2007 May 29 1
38 16621444 ANP-mediated cGMP signaling and phosphodiesterase inhibition in the rat cervical spinal cord. 2006 Jun 1
39 15599707 Comparative study of the vasorelaxant activity, superoxide-scavenging ability and cyclic nucleotide phosphodiesterase-inhibitory effects of hesperetin and hesperidin. 2004 Dec 1
40 12834273 cGMP-phosphodiesterase activity is up-regulated in response to pressure overload of rat ventricles. 2003 May 1
41 12003819 Natriuretic peptide receptor-B in adult rat ventricle is predominantly confined to the nonmyocyte population. 2002 Jun 3
42 12065724 Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus. 2002 Jul 3
43 12107056 Attenuation of cAMP accumulation in adult rat cardiac fibroblasts by IL-1beta and NO: role of cGMP-stimulated PDE2. 2002 Aug 2
44 12221013 Changes in phosphodiesterase activity in the developing rat submandibular gland. 2002 Aug 3
45 12358727 Kinetics of nitric oxide-cyclic GMP signalling in CNS cells and its possible regulation by cyclic GMP. 2002 Oct 3
46 11150485 The effects of phosphodiesterase inhibition on cyclic GMP and cyclic AMP accumulation in the hippocampus of the rat. 2001 Jan 12 3
47 11181844 Nerve growth factor inhibits PC12 cell PDE 2 phosphodiesterase activity and increases PDE 2 binding to phosphoproteins. 2001 Feb 1
48 11532906 Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. 2001 Aug 31 1
49 10704943 Inactivation of atrial natriuretic factor-stimulated cyclic guanosine 3',5'-monophosphate (cGMP) in UMR-106 osteoblast-like cells. 2000 May 1 4
50 10913949 Role of phosphodiesterase and protein kinase G on nitric oxide-induced inhibition of prolactin release from the rat anterior pituitary. 2000 Aug 2